Tag: cancer diagnostics

Press Releases

Olink AB and Bethyl sign distribution agreement for the US market

Nov 21, 2011 09:00 EST Olink Bioscience, a Sweden based biotechnology company focused on innovative protein detection technologies, has entered into a distribution agreement with Bethyl Laboratories, Inc. Together with Bethyl Olink Bioscience will continue to expand the distribution of the Duolink® product line in the US market.

Aug 29, 2011 08:20 EDT nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB to purchase 49 % of the outstanding shares in the company. The intention is to accelerate the growth and value creation of the company by injecting knowledge, experience and financial strength to complement Olink’s unique product and technology position.

Apr 27, 2011 09:21 EDT Proseek™ is a user friendly open assay development reagent kit for the detection and quantification of proteins in serum or plasma samples. It offers the same level of performance as ELISA, but uses extremely low sample volumes; only1 µl is required for each reaction thus enabling the scientist to study precious bio-banked materials and plasma from small laboratory animals.

Show all 9 press releases »

News

New products; Duolink® II Detection Reagents Far Red and Green

Oct 11, 2010 09:27 EDT Olink Bioscience launches two new Detection Reagents; Duolink® II Detection Reagents Far Red and Green.

Contact persons

Mats Gullberg - Cheif Technology  Officer

Previously Dr Gullberg worked for 10 years at Uppsala University where he also earned his Ph.D. The focus of his work since 1999 has been proximity ligation, rolling circle amplification and selector technology, all core technologies of Olink Bioscience.